Literature DB >> 15968576

Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions.

Robert V Considine1.   

Abstract

Leptin is synthesized and secreted primarily by adipocytes, and is present in serum in direct proportion to the amount of adipose tissue. The primary role of leptin is to provide to the central nervous system a signal of energy intake and energy stores in the body so that the hypothalamus can efficiently maintain a stable body weight. The receptor for leptin in the hypothalamus signals by activation of an associated janus kinase which phosphorylates signal transducer and activator of transcription (STAT) proteins that regulate neuronal gene expression. Genetic mutations in leptin and its receptor can result in obesity in both rodents and humans, supporting a central role for leptin in the regulation of body weight. Leptin has also been implicated in a variety of physiological processes other than body weight homeostasis. Many of these functions are mediated through the central nervous system; however, the presence of leptin receptors in tissues throughout the body suggests that leptin can also have direct effects on cells and tissues. Serum leptin levels have been associated with cardiovascular risk factors after correction for adiposity. Leptin can promote platelet aggregation, which requires expression of functional leptin receptors on the platelet. Leptin-induced increases in sympathetic nerve activity have been suggested to contribute to hypertension, and leptin has been observed to increase oxidative stress in cultured endothelial cells. Many of these pathophysiologic effects of leptin on the vasculature are most likely of importance when leptin levels are elevated in obese subjects due to resistance to the weight-reducing effects of the hormone. An improved understanding of the effects of leptin on the vasculature will provide valuable insight into the relationship between obesity and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968576     DOI: 10.1055/s-2005-871738

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  21 in total

1.  The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.

Authors:  Avi Amrami-Weizman; Rachel Maayan; Irit Gil-Ad; Artashez Pashinian; Camil Fuchs; Moshe Kotler; Michael Poyurovsky
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

2.  High-fat diet-induced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice.

Authors:  Kristy L Townsend; Magen M Lorenzi; Eric P Widmaier
Journal:  Endocrine       Date:  2008-05-16       Impact factor: 3.633

Review 3.  The role of obesity in the pathogenesis of hypertension.

Authors:  Yolanda E Bogaert; Stuart Linas
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

4.  Effects of leptin on intake of specific micro- and macronutrients in a woman with leptin gene deficiency studied off and on leptin at stable body weight.

Authors:  Julio Licinio; Michael Milane; Sarika Thakur; Fiona Whelan; Bulent O Yildiz; Tuncay Delibasi; Patricia B de Miranda; Metin Ozata; Erol Bolu; Alex Depaoli; Ma-Li Wong
Journal:  Appetite       Date:  2007-04-06       Impact factor: 3.868

5.  Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.

Authors:  Gabriel Y Lai; Edward L Giovannucci; Michael N Pollak; Sarah B Peskoe; Meir J Stampfer; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-03-25       Impact factor: 2.506

6.  Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population.

Authors:  Justo Sierra-Johnson; Abel Romero-Corral; Francisco Lopez-Jimenez; Apoor Suresh Gami; Fatima Helena Sert Kuniyoshi; Robert Wolk; Virend Kristen Somers
Journal:  Am J Cardiol       Date:  2007-05-30       Impact factor: 2.778

7.  Maternal obesity in pregnancy and respiratory health in early childhood.

Authors:  Siri E Håberg; Hein Stigum; Stephanie J London; Wenche Nystad; Per Nafstad
Journal:  Paediatr Perinat Epidemiol       Date:  2009-07       Impact factor: 3.980

8.  Human soluble leptin receptor concentration in healthy offspring of hypertensive parents.

Authors:  Dimitris P Papadopoulos; Thomas K Makris; Maria Poulakou; Urania G Papazachou; Antonios N Hatzizacharias; Despina N Perrea; Vassilios E Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

9.  Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects.

Authors:  Saimai Chatree; Chantacha Sitticharoon; Pailin Maikaew; Kitchaya Pongwattanapakin; Issarawan Keadkraichaiwat; Malika Churintaraphan; Chanakarn Sripong; Rungnapa Sririwichitchai; Sompol Tapechum
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-12

10.  Nationwide Cross-Sectional Study of the Association between Knee Pain and Weight Change: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES 2013-2015).

Authors:  Sungwoo Choi; Sangun Nah; Hae-Dong Jang; Seung-Hee Cheon; Ji-Eun Moon; Sangsoo Han
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.